Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date ICMJE | June 24, 2007 | ||||
Last Updated Date | May 24, 2011 | ||||
Start Date ICMJE | January 2011 | ||||
Estimated Primary Completion Date | January 2012 (final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
Does screening for BV using VS-SENSE in pregnant women with h/o preterm delivery or with premature contractions, and treatment will reduce or prevent Late miscarriage, preterm birth, preterm PROM, chorioamnionitis, and postpartum endometritis. [ Time Frame: One year ] [ Designated as safety issue: No ] | ||||
Original Primary Outcome Measures ICMJE |
Does screening for BV using VS-SENSE in pregnant women with h/o preterm delivery or with premature contractions, and treatment will reduce or prevent Late miscarriage, preterm birth, preterm PROM, chorioamnionitis, and postpartum endometritis. [ Time Frame: One year ] | ||||
Change History | Complete list of historical versions of study NCT00491270 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures ICMJE | |||||
Original Secondary Outcome Measures ICMJE | |||||
Current Other Outcome Measures ICMJE | |||||
Original Other Outcome Measures ICMJE | |||||
Descriptive Information | |||||
Brief Title ICMJE | Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery | ||||
Official Title ICMJE | Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery | ||||
Brief Summary | To determine whether screening of pregnant women with history of previous preterm delivery or with premature contractions for bacterial vaginosis using VS-SENSE, and treatment of positive women will reduce the risk of spontaneous preterm birth. |
||||
Detailed Description | This is an open-label, comparative, and prospective study. Pregnant women, pregnancy week 26 to 36+6, between the ages 18-45, who were hospitalized in the high risk department, with history of previous preterm delivery and/or with premature contractions. Patient with premature ruptured membrane will be excluded. In the hospital pregnant women with history of previous preterm delivery or with premature contractions, (participants) will be examined by speculum with no lubricant, The clinician will use the VS-SENSE to sample vaginal secretions and will immediately observe and record the color obtained.Should the VS-SENSE produce positive results the physician will consider giving clindamycin treatment. |
||||
Study Type ICMJE | Interventional | ||||
Study Phase | Phase 3 | ||||
Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Caregiver) Primary Purpose: Diagnostic |
||||
Condition ICMJE |
|
||||
Intervention ICMJE | Device: VS Sense
An applicator to diagnose pH increase above 5.2 |
||||
Study Arm (s) | |||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Not yet recruiting | ||||
Estimated Enrollment ICMJE | 100 | ||||
Estimated Completion Date | August 2013 | ||||
Estimated Primary Completion Date | January 2012 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Female | ||||
Ages | 18 Years to 45 Years | ||||
Accepts Healthy Volunteers | Yes | ||||
Contacts ICMJE |
|
||||
Location Countries ICMJE | Israel | ||||
Administrative Information | |||||
NCT Number ICMJE | NCT00491270 | ||||
Other Study ID Numbers ICMJE | F-7-20.6-1 VER-1 | ||||
Has Data Monitoring Committee | Yes | ||||
Responsible Party | Commonsense, Commonsense, Cesarea | ||||
Study Sponsor ICMJE | Western Galilee Hospital-Nahariya | ||||
Collaborators ICMJE | Common Sense | ||||
Investigators ICMJE |
|
||||
Information Provided By | Western Galilee Hospital-Nahariya | ||||
Verification Date | May 2011 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |